Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lexagene Holdings's Average Total Inventories for the quarter that ended in Nov. 2022 was $1.47 Mil. Lexagene Holdings's Revenue for the
three
months ended in Nov. 2022 was $0.04 Mil.
Lexagene Holdings's Inventory-to-Revenue for the quarter that ended in Nov. 2022 was 34.15.
Lexagene Holdings's Inventory-to-Revenue for the quarter that ended in Nov. 2022
increased
from Aug. 2022 (23.93) to Aug. 2022 (34.15)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Lexagene Holdings's Days Inventory for the
three
months ended in Nov. 2022 was 705.27.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Lexagene Holdings's Inventory Turnover for the quarter that ended in Nov. 2022 was 0.13.
Lexagene Holdings Inventory-to-Revenue Historical Data
The historical data trend for Lexagene Holdings's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lexagene Holdings's Inventory-to-Revenue
For the Medical Devices subindustry, Lexagene Holdings's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lexagene Holdings's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Lexagene Holdings's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lexagene Holdings's Inventory-to-Revenue for the fiscal year that ended in Feb. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Lexagene Holdings's Days Inventory for the
three
months ended in Nov. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lexagene Holdings Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Lexagene Holdings's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Lexagene Holdings (Lexagene Holdings) Business Description
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LXXGQ has been successfully added to your 